AUD 0.92
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -12.51 Million AUD | -368.57% |
2023 | -2.67 Million AUD | 7.77% |
2022 | -3.09 Million AUD | 3.76% |
2021 | -3.21 Million AUD | -183.02% |
2020 | -1.13 Million AUD | -131.15% |
2019 | -423.52 Thousand AUD | -176.21% |
2018 | -178.85 Thousand AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - AUD | -239.11% |
2024 Q4 | -4.57 Million AUD | -26.34% |
2024 Q3 | -3.62 Million AUD | 29.04% |
2024 Q1 | -2.43 Million AUD | -70.17% |
2024 Q2 | -5.11 Million AUD | -109.37% |
2023 Q4 | -1.47 Million AUD | -104.99% |
2023 Q2 | -1.38 Million AUD | -124.61% |
2023 FY | - AUD | 7.77% |
2023 Q1 | -617.9 Thousand AUD | -13.43% |
2023 Q3 | -717.16 Thousand AUD | 48.33% |
2022 Q2 | -2.11 Million AUD | -111.54% |
2022 Q1 | -998.6 Thousand AUD | -9.68% |
2022 FY | - AUD | 3.76% |
2022 Q4 | -544.73 Thousand AUD | -0.41% |
2022 Q3 | -542.53 Thousand AUD | 74.32% |
2021 Q4 | -910.48 Thousand AUD | -116.96% |
2021 FY | - AUD | -183.02% |
2021 Q3 | -419.64 Thousand AUD | 82.78% |
2021 Q2 | -2.43 Million AUD | -101.48% |
2021 Q1 | -1.2 Million AUD | -136.43% |
2020 FY | - AUD | -131.15% |
2020 Q2 | -626.06 Thousand AUD | -100.0% |
2020 Q4 | -511.68 Thousand AUD | -92.04% |
2020 Q3 | -266.44 Thousand AUD | 57.44% |
2020 Q1 | -313.02 Thousand AUD | 0.0% |
2019 FY | - AUD | -176.21% |
2018 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Althea Group Holdings Limited | -28.56 Million AUD | 56.194% |
Cann Group Limited | -35.53 Million AUD | 64.792% |
ECS Botanics Holdings Ltd | 3.22 Million AUD | 487.557% |
Ecofibre Limited | -38.34 Million AUD | 67.37% |
Elixinol Wellness Limited | -6.8 Million AUD | -83.83% |
Hygrovest Limited | -1.1 Million AUD | -1034.314% |
IDT Australia Limited | -5.13 Million AUD | -143.746% |
Invion Limited | -4.57 Million AUD | -173.669% |
Little Green Pharma Ltd | -4.64 Million AUD | -169.451% |
Medical Developments International Limited | -29.44 Million AUD | 57.51% |
Vitura Health Limited | 7.07 Million AUD | 276.809% |
Vita Life Sciences Limited | 13.09 Million AUD | 195.522% |